Acutus Medical, Inc.
NASDAQ:AFIB
0.042 (USD) • At close April 2, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|
| Revenue
| 20.157 | 7.164 | 16.363 | 17.263 | 8.464 | 2.836 | 2.166 |
| Cost of Revenue
| 19.144 | 10.301 | 31.91 | 32.925 | 15.889 | 9.243 | 7.51 |
| Gross Profit
| 1.013 | -3.137 | -15.547 | -15.662 | -7.425 | -6.407 | -5.344 |
| Gross Profit Ratio
| 0.05 | -0.438 | -0.95 | -0.907 | -0.877 | -2.259 | -2.467 |
| Reseach & Development Expenses
| 0 | 3.482 | 28.153 | 36.683 | 33.454 | 38.029 | 19.077 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 26.847 | 13.33 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 26.847 | 13.33 |
| SG&A
| 10.436 | 7.742 | 47.654 | 63.523 | 50.357 | 26.847 | 13.33 |
| Other Expenses
| -9.366 | 0 | 0 | 0 | 0.097 | 0 | 0 |
| Operating Expenses
| 1.07 | 11.224 | 75.807 | 100.206 | 83.811 | 64.876 | 32.407 |
| Operating Income
| -0.057 | -14.361 | -27.339 | -112.122 | -91.333 | -72.569 | -37.751 |
| Operating Income Ratio
| -0.003 | -2.005 | -1.671 | -6.495 | -10.791 | -25.589 | -17.429 |
| Total Other Income Expenses Net
| -4.479 | 2.503 | -12.195 | -5.561 | -10.625 | -24.47 | -10.156 |
| Income Before Tax
| -4.536 | -11.858 | -39.534 | -117.683 | -101.958 | -97.039 | -47.907 |
| Income Before Tax Ratio
| -0.225 | -1.655 | -2.416 | -6.817 | -12.046 | -34.217 | -22.118 |
| Income Tax Expense
| 0 | 0.063 | 0.082 | 5.677 | 0.023 | 22.268 | -4.925 |
| Net Income
| -9.547 | -81.663 | -39.616 | -123.36 | -101.981 | -119.307 | -47.907 |
| Net Income Ratio
| -0.474 | -11.399 | -2.421 | -7.146 | -12.049 | -42.069 | -22.118 |
| EPS
| -0.32 | -2.807 | -1.391 | -4.107 | -8.94 | -3.538 | -1.747 |
| EPS Diluted
| -0.32 | -2.807 | -1.391 | -4.107 | -8.94 | -3.538 | -1.747 |
| EBITDA
| 2.249 | -5.329 | 35.205 | -105.116 | -91.333 | -68.116 | -40.555 |
| EBITDA Ratio
| 0.112 | -0.744 | 2.152 | -6.089 | -10.791 | -24.018 | -18.723 |